CONCENTRAID Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Concentraid, and what generic alternatives are available?
Concentraid is a drug marketed by Ferring and is included in one NDA.
The generic ingredient in CONCENTRAID is desmopressin acetate. There are twenty drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the desmopressin acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Concentraid
A generic version of CONCENTRAID was approved as desmopressin acetate by MEITHEAL on October 15th, 1997.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CONCENTRAID?
- What are the global sales for CONCENTRAID?
- What is Average Wholesale Price for CONCENTRAID?
Summary for CONCENTRAID
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 18 |
| Patent Applications: | 5 |
| DailyMed Link: | CONCENTRAID at DailyMed |
US Patents and Regulatory Information for CONCENTRAID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ferring | CONCENTRAID | desmopressin acetate | SOLUTION;NASAL | 019776-001 | Dec 26, 1990 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
